RUBFILA2026-09-05RUBFILA2026-09-052026-09-05ResolutionOrAgendaDomain1RUBFILA2026-09-05ResolutionOrAgendaDomain1RUBFILA2026-09-052026-09-05ResolutionOrAgendaDomain2RUBFILA2026-09-05ResolutionOrAgendaDomain2RUBFILA2026-09-052026-09-05ResolutionOrAgendaDomain3RUBFILA2026-09-05ResolutionOrAgendaDomain3RUBFILA2026-09-052026-09-05ResolutionOrAgendaDomain4RUBFILA2026-09-05ResolutionOrAgendaDomain4RUBFILA2026-09-052026-09-05ResolutionOrAgendaDomain5RUBFILA2026-09-05ResolutionOrAgendaDomain5iso4217:INRxbrli:pureRUBFILARUBFILA INTERNATIONAL LIMITEDNew2026-09-2911:00:002026-09-05Annual General MeetingVideo Conference (VC) or Other Audio-Visual Means (OAVM)33Tuesday2026-09-2911:00:00Video Conference (VC) or Other Audio-Visual Means (OAVM)5Ordinary ResolutionAdoption of Financial StatementsTo receive, consider and adopt. a) the Audited Standalone Financial Statements of the Company for the financial year ended 31st March, 2026 including Audited Balance Sheet as at 31st March, 2026 and the Statement of Profit and Loss, Cash Flow Statement and Statement of Changes in Equity for the financial year ended on that date and the reports of the Board of Directors and Statutory Auditors thereon ; b) the Audited Consolidated Financial Statements of the Company for the financial year ended 31st March 2026, including Audited consolidated Balance Sheet as at 31st March, 2026 and the Statement of Profit and Loss, Cash Flow Statement and Statement of Changes in Equity for the financial year ended on that date and the reports of the Statutory Auditors thereon.Ordinary ResolutionIssuance/Corporate ActionDividendTo declare a final dividend of Rs. 2.00/- per equity share of Rs. 5/- (40%) each for the Financial Year ended 31st March, 2026.Ordinary ResolutionAppointment/Re-appointment/Removal/Ratification/Retirement/RemunerationRetirement by rotationTo appoint a Director in place of Mr. Hardik B Patel (holding DIN 00590663), who retires by rotation in terms of Section 152(6) of Companies Act, 2013 and being eligible offers himself for reappointment.OthersChairpersonMr.Hardik B Patel2025-09-252026-09-29Ordinary ResolutionAppointment/Re-appointment/Removal/Ratification/Retirement/RemunerationRemunerationTo ratify the remuneration payable to M/s. Ajith Sivadas & Co. Cost Auditors of the Company for the year ending 31st March 2027 “RESOLVED THAT pursuant to the provision of Section148(3) and other applicable provisions, if any, of the Companies Act, 2013 and the Companies (Audit and Auditors) Rules, 2014, (including any statutory modification(s) or any amendment(s) thereto or any substitution(s) or any reenactments thereof for the time being in force),the Company hereby ratify the remuneration of Rs.75,000/- (Rupees Seventy Five Thousand only) plus applicable taxes and re-imbursement of out of pocket expenses incurred by them in connection with the aforesaid audit payable to cost auditors M/s. Ajith Sivadas & Co, Cost Accountants, Palakkad (FRN: 102805) who have been appointed by the Board of Directors on the recommendation of audit committee.as the Cost auditors of the Company to Conduct cost audit of the records maintained by the Company for the year ending 31st March 2027 as prescribed under the Companies (Audit and Auditors) Rules, 2014”. “RESOLVED FURTHER THAT the Board of Directors of the Company be and are hereby authorized severally to do all acts, deeds, things and take all such steps as may be necessary, proper or expedient to give effect to this resolution.”OthersCost AuditorsM/s. Ajith Sivadas & Co.2026-04-012027-03-3175000Special ResolutionOthersOthersTo ratify the Divestment of the entire shareholding of the company in Premier Tissues India LtdTo ratify the Divestment of the entire shareholding of the company in Premier Tissues India Ltd.“RESOLVED THAT pursuant to the applicable provisions of Sections 188 and 102 and other applicable provisions of the Companies Act, 2013 (“Act”), read with the rules made thereunder, including Rule 15 of the Companies (Meetings of Board and its Powers) Rules, 2014, and pursuant to Regulations 23, 24(5) and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR Regulations”), as amended from time to time, and subject to such other approvals, consents, permissions and sanctions as may be required under applicable laws, and in accordance with the Articles of Association of the Company and the Company’s Policy on Related Party Transactions, approval of the Members of the Company be and is hereby accorded for the proposed sale/divestment by the Company of its entire shareholding comprising 11240854 equity shares of ₹10 each, constituting 100% of the issued, subscribed and paid-up equity share capital of its wholly-owned subsidiary, Premier Tissues India Limited (“PTIL”), to M/s.Finquest Personal Care Pvt. (CIN U20230MH2026PTC471920), a Related Party of the Company, at a consideration of ₹54.26 per equity share, aggregating to ₹61 Crores (Rupees Sixty One Crores only), on the terms and conditions disclosed in the Explanatory Statement annexed to the Notice and subject to compliance with all applicable statutory and regulatory requirements. RESOLVED FURTHER THAT the aforesaid transaction be and is hereby approved as a Related Party Transaction under Section 188 of the Act and Regulation 23 of the SEBI LODR Regulations, it being expressly recorded that the transaction is not being undertaken on an arm’s length basis, and that the consideration payable by M/s.Finquest Personal Care Pvt. (CIN U20230MH2026PTC471920), is higher than the values determined by the two independent Registered Valuers appointed by the Company, as more particularly disclosed in the Explanatory Statement annexed to the Notice.11 RESOLVED FURTHER THAT pursuant to Regulation 24(5) of the SEBI LODR Regulations, approval of the Members be and is hereby accorded for the disposal by the Company of its entire shareholding in PTIL, resulting in reduction of the Company’s shareholding therein to nil and cessation of control over PTIL. RESOLVED FURTHER THAT the Board of Directors of the Company, including any Committee thereof duly authorised by the Board, be and is hereby authorised to finalise, execute and deliver the share purchase agreement and all other agreements, deeds, documents and writings in connection with the proposed transaction, determine the completion date and other implementation terms consistent with the terms approved by the Members, receive the consideration and complete the transfer of shares of PTIL, obtain such approvals, consents and permissions as may be required, make necessary filings and disclosures with the stock exchanges, Registrar of Companies and other regulatory and statutory authorities, and to do all such acts, deeds, matters and things as may be necessary, desirable or expedient for giving effect to this resolution, provided that no such modification shall materially alter the nature or commercial substance of the transaction or increase the consideration payable by the Company or reduce the consideration receivable by the Company from the amount approved by the Members.”